Pasithea Therapeutics Corp. (KTTAW) NASDAQ

0.01

-0.001(-8.33%)

Updated at January 13 09:38AM

Currency In USD

Valuation

Market Cap3.45M
Enterprise Value-3.47M
P/E Ratio-0.48
PEG Ratio-0.02
Price/Sales Ratio0
Price/Book Ratio0.53
Enterprise/Revenue0
Enterprise/EBITDA-0.18

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.99
Return On Equity-0.98

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-13.6M
Net Income-13.9M
Diluted EPS-12.69

Balance Sheet

Total Cash4.12M
Total Cash/Share0.55
Total Debt0
Total Debt/Equity0
Current Ratio4.02
Book Value Per Share1.64

Price History

52-Week Change-56.18
52-Week High0.01
52-Week Low0.01
Moving Average 50 Days0.02
Moving Average 200 Days0.02

Statistics

Average Volume42,127.12
Shares Outstanding7.44M
% Held by Institutions7.79

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A